Study of JKN2501 in healthy volunteers
Part of Infections, Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests a new drug called JKN2501 in healthy people to find the best and safest dose. It is the first time this drug is being given to humans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 26.
- You weigh at least 50 kg (110 lbs) if male or 45 kg (99 lbs) if female.
- You are generally healthy based on medical history and basic tests.
- You agree to use effective birth control from now until 90 days after the last dose.
- You have not used any medications or supplements in the past 2 weeks without approval.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new investigational drug called KR25102 in healthy volunteers to see how safe it is and how the body processes it. The study also includes optional pain-sensitivity testing for some participants.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This study checks how a new drug interacts with the body. It is for healthy volunteers to see if the drug is safe and how it works in the body.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.